Assessing response rates in clinical trials of treatment for relapsed or refractory multiple myeloma: A study of bortezomib and thalidomide by H Prince, Brad Schenkel and Linda Mileshkin [8]

B. G.M. Durie, S. V. Rajkumar

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)821
Number of pages1
Issue number4
StatePublished - Apr 2007

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this